Plk3 inhibitor
Webb(a) Representative photomicrographs of Day 4 lenses after inhibitor addition (Plk3 inhibitor GW843682X 1 μM, Atm inhibitor KU55933 10 μM). GW843682X or KU55933 was added … Webb20 juni 2024 · PLK3 was suggested to control cell response to various forms of stress including osmotic stress, hypoxia, DNA damage, and Golgi stress . Whereas PLK1 is rapidly inhibited after stress, activity of PLK3 is believed to be stimulated by stress [10,12,13].
Plk3 inhibitor
Did you know?
WebbInhibitor. 99.50%. Copanlisib (BAY 80-6946) is a potent, selective and ATP-competitive pan-class I PI3K inhibitor, with IC50 s of 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, … WebbRigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Rigosertib inhibits PI3K/Akt pathway and activates oxidative stress signals. Rigosertib induces apoptosis in various cancer cells. Phase 3. HMN-214
WebbVolasertib (BI 6727) is an orally active, highly potent and ATP-competitive Polo-like kinase 1 (PLK1) inhibitor with an IC50 of 0.87 nM. Volasertib inhibits PLK2 and PLK3 with IC50s of 5 and 56 nM, respectively. Volasertib induces mitotic arrest and apoptosis. Volasertib, a dihydropteridinone derivative, shows marked antitumor activity in multiple cancer models. Webb24 juni 2024 · Inhibition of PLK3 attenuates TEC apoptosis after I/R injury by blocking the ATM/P53-mediated DDR. Therefore, PLK3 may serve as a potential therapeutic target for …
Webb30 apr. 2009 · BI 6727 potently inhibited Plk1 as well as the two closely related kinases Plk2 and Plk3 (IC 50 values 0.87, 5, and 56 nmol/L, respectively). In contrast, assays using a panel of >50 other kinases (listed in ref. 19 ) failed to identify any inhibitory activity at concentrations up to 10 μmol/L. WebbGW843682X is a selective, ATP-competitive inhibitor of PLK1 and PLK3, with IC50 s of 2.2 nM and 9.1 nM, respectively, and is also >100-fold selective against ∼30 other kinases. …
WebbInhibitors of mitotic protein kinases are currently being developed as non-neurotoxic alternatives of microtubule-targeting agents (taxanes, vinca alkaloids) which provide a …
Webb26 okt. 2024 · PLK3 inhibits proliferation and glucose metabolism of CRC cells The expression of PLK3 in eight CRC cell lines was detected. As shown in Additional file 2: Figure S1a and b, PLK3 was differently expressed and especially high in HCT116 and HT29, but low in SW480 and RKO. dapper laughs o2WebbPlk3(-/-) mice displayed an increase in weight and devel-oped tumors in various organs at an advanced age [22]. Many tumors in Plk3(-/-) mice were large in size, exhibiting enhanced angiogenesis. In addition, Plk3 is frequently down-regulated in human tumors (lung, head, and neck) which could be due to a loss of heterozygosity of the Plk3 gene ... dapper internet cardWebb24 juni 2009 · To unravel the growth inhibition mechanism of Polo-like kinase 3 (Plk3), the effect of overexpression of Plk3 was examined in 293T cells. Cell rounding, changes in actin organization and cellular detachment were induced by Plk3 transfection in a kinase activity-dependent manner. dapper investors